http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GE-P20227340-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75
filingDate 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce2c0fc7748b875f7f1494e86da4c4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a867b2d30ffc121dfaa807b709a456b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69428a8534925b0978e14458ca7d4800
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa997043970927924bbfc4cdfa44a300
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dfff7328ce13cf487b46161b5f89b62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e32d980ccf71affd92d470b9d4807600
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f74dd9b3fd02560bf61025a4cbbc7485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fbf91f47ccb035041b56ad658039b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49c062b672aca8c286e21b30a6d671b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad33a2df068ed07104faf5cd078f0c33
publicationDate 2022-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GE-P20227340-B
titleOfInvention Synthesis of omecamtiv mecarbil
abstract Present invention relates to novel intermediate compounds – piperazine methyl carboxylate (PMEC) phosphate hydrate, and methyl-4-(2-fluo¬rine-3-nytro benzyl) piperazine-1-carboxylate, intended for omecamtiv mecarbil synthesis, and preparation methods thereof. ts
priorityDate 2017-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420313976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21904562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11689883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22023151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452895221

Total number of triples: 33.